According to Wei et al., NLRP3 expression is upregulated in inflammatory liver tissue but downregulated in cancerous tissue, suggesting that NLRP3 deficiency may contribute to hepatocellular carcinoma progression [136]. This evidence concerns the gene NLRP3 and hepatocellular carcinoma.